Angioscore, Inc. v. Trireme Medical, Inc.
Opinion
Lead Opinion
Rogers, J.
Ordek ConstruiNG Claims in Dispute; Granting in Part and Denying in Part Defendants’ Motion for Summary Judgment of Non-Infringement
INTRODUCTION
At the heart of this patent action is an angioplasty device named “Chocolate.” *1280 Defendant Eitan Konstantino, an inventor of angioplasty devices, worked for plaintiff AngioScore, Inc. (“AngioScore”), a company that makes and sells angioplasty devices. Later, he started his own company, TriReme Medical, Inc., which has since reorganized as defendant TriReme Medical, LLC (“TriReme”). TriReme makes and sells the Chocolate device. AngioS-core’s operative Supplemental and Second Amended Complaint alleges that Chocolate infringes United States Patent No. 7,691,119, which AngioScore owns by assignment. (Dkt. No. 118 ¶¶ 14, 19; id., Ex. A (“ '119 Patent”).) AngioScore brings a single claim of patent infringement against TriReme, Konstantino, and two corporate entities associated with TriReme, namely, Quattro Vascular Pte Ltd. (“Quattro”), and QT Vascular Ltd. (f/k/a QT Vascular Pte. Ltd.) (“QTV”). 1 Defendants answered, asserting counterclaims for (1) a declaration of noninfringement of the '119 Patent, (2) a declaration of invalidity of…